MILAE BIORESOURCES CO. LTD.

MILAE BIORESOURCES CO. LTD.

KKRX:218150
1,780.00
KRW
-30.00
(-1.66%)
-172.72EPS
33.88BMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
11,680.91
11,606.38
2,080.5
2,820.66
2,694.63
3,733.89
4,085.15
3,127.63
3,169.51
3,461.19
3,604.74
Basic EPS, GAAP
6
479.8
-567.33
105
58
54
64
52
23
-22
-167
-186.95
Free Cash Flow per Basic Share
-7.08
-387.93
442.75
-363.22
175.38
35.66
136.45
38.02
135.58
-54.32
202.21
10.78
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1,979.58
4,619.38
1,538.62
1,597.99
1,667.62
1,720.97
1,854.08
2,147.25
2,264.77
2,235.66
2,071.61
2,057.83
Tangible Book Value per Share
1,979.58
4,619.38
1,538.62
1,597.99
1,667.59
1,628.46
1,765.94
2,051.06
2,192.55
1,764.27
1,697
1,693.59
Basic Weighted Avg Shares
3
4
4
17
18
18
18
19
19
20
20
20
Sales/Revenue/Turnover
- -
41,234
40,927
35,199
50,079
47,497
66,668
75,635
60,016
62,453
67,555
72,464
Operating Margin (%)
- -
6.3
3.7
5.63
2.93
2.98
2.78
2.09
0.03
0.29
-2.13
-1.33
Depreciation Expense
- -
164
171
283
658
720
921
1,029
1,056
1,173
2,238
2,183
Net Income, GAAP
17
1,694
-2,001
1,776
1,030
952
1,143
963
441
-433
-3,259
-3,758
Effective Tax Rate (%)
22
18.54
- -
6.04
17.63
7.84
5.71
3.01
8.59
- -
- -
- -
Profit Margin (%)
- -
4.11
-4.89
5.05
2.06
2
1.71
1.27
0.74
-0.69
-4.82
-5.19
Working Capital
8,496
12,005
20,039
16,767
18,054
17,089
34,092
27,031
30,809
16,207
16,596
14,162
LT Debt
1,479
- -
1,455
- -
216
152
14,856
311
288
480
346
1,523
Total Equity
6,988
16,306
24,664
28,423
29,661
30,687
33,059
40,835
44,160
45,672
42,753
39,984
Return on Invested Capital (%)
- -
14.24
- -
6.27
3.76
3.89
4.14
3
0.04
- -
- -
- -
Return on Capital (%)
- -
11.69
- -
6.66
3.93
3.39
4.52
3.34
1.78
- -
- -
- -
Return on Common Equity (%)
- -
14.54
-9.77
6.69
3.55
3.17
3.61
2.62
1.04
-0.99
-7.76
-8.9

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
9,179
9,311
9,362
LT Borrowings
111
910
1,346
LT Finance Leases
235
194
178
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
19
19
19
Market Capitalization
57,999
59,169
33,883

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
31,590
32,810
33,833
Cash, Cash Equivalents & STI
16,332
15,443
14,766
Accounts Receivable, Net
8,234
8,341
10,060
Inventories
6,364
8,295
8,316
Total Current Liabilities
14,993
15,732
19,672
Payables & Accruals
- -
- -
- -
ST Debt
9,179
9,311
9,362
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
24.41%
7.28%
-6.39%
Free Cash Flow
556.15%
-24.77%
-468.75%
Net Income, GAAP
965.68%
80.76%
651.9%
Sales/Revenue/Turnover
- -
9.08%
8.17%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
14,449
15,585
18,523
13,897
62,453
2025
14,704
16,765
18,691
17,395
67,555
2026
17,038
19,340
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
12
-11
32
-55.37
-22
2025
27
7
41.45
-256.39
-167
2026
25.55
-3
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Sung-Jin Kim
Full Time Employees
56
Sector
Process industries
Industry
Chemicals: specialty
Address
Seoul South Korea
IPO Date
Jun 18, 2015
Business
MILAE BIORESOURCES CO., LTD. is a South Korea-based biotechnology and animal nutrition company primarily engaged in the development, manufacturing, and distribution of specialized animal feed additives, functional livestock nutrition, companion animal care products, and bio-based ingredients. Founded in 1998 and headquartered in Seoul, South Korea, with primary manufacturing, quality control, and research facilities located in Icheon, Gyeonggi-do, the company operates across two core business divisions: Animal Nutrition and Companion Animal Care. The company's product and service offerings comprise: specialized functional feed additives, including multi-enzyme complexes, acidifiers, probiotics, phytogenic extracts, emulsifiers, flavoring agents, sweetener formulations, and amino acid premixes designed to improve feed conversion efficiency and animal gut health; specialized young animal nutrition, including early-weaning piglet creep feeds, prestarter and starter feeds, milk replacers, and immune-enhancing specialty formulas; bio-fermented materials, including high-protein fermented soybean meals, bioactive peptides, and spray-dried functional egg yolk powder; companion animal care products, featuring premium dry and wet pet foods, functional nutritional treats, joint and digestive health supplements, and oral care products sold under proprietary brands such as Tiaholic as well as through original equipment manufacturer (OEM) and original design manufacturer (ODM) channels; and raw ingredient trading, covering the import and domestic supply of agricultural grain derivatives and specialty feed ingredients. MILAE BIORESOURCES serves livestock feed millers, agricultural cooperatives, farming conglomerates, pet retailers, and veterinary clinics domestically, while exporting functional additives to regional markets across Southeast Asia and East Asia, including Vietnam, the Philippines, and China. In recent developments, the company has actively accelerated its business diversification by scaling its pet health and wellness portfolio, investing in smart manufacturing upgrades and automated packaging lines at its Icheon production plant, and expanding direct-to-consumer e-commerce channels. Additionally, MILAE BIORESOURCES has broadened strategic research collaborations with bio-venture institutes to develop next-generation alternative protein sources, natural antibiotic-replacement formulations, and microbiome-derived feed solutions to address global sustainable livestock and pet nutrition demands.